First described in the early 1980s, antiphospholipid syndrome (APS) is a unique form of
acquired autoimmune thrombophilia in which patients present with clinical features of …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous
thromboembolism, arterial thrombosis, and obstetric morbidities in the setting of persistently …

Antiphospholipid antibody syndrome (APS) is an autoimmune acquired thrombophilia
characterized by recurrent thrombosis and pregnancy morbidity in the presence of …

Antiphospholipid antibodies are a heterogeneous group of autoantibodies that have clear
associations with thrombosis and pregnancy morbidity, and which together constitute the …

Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy
complications in the presence of persistent antiphospholipid antibodies (APLA). Laboratory …

Background Antiphospholipid syndrome (APS) is characterized by the presence of
circulating antiphospholipid antibodies (aPL) in patients with thrombosis and/or pregnancy …

Background Patients with the lupus anticoagulant (LA) are at an increased risk of thrombotic
events, which in turn increase the risk of death. Understanding the determinants of …

Complement system homeostasis is important for host self-protection and anti-microbial
immune surveillance, and recent research indicates roles in tissue development and …

Abstract Diluted Russell Viper Venom Time (dRVVT) has become the most popular test to
detect Lupus Anticoagulant (LA). dRVVT is more sensitive than other global tests employed …

Abstract Purpose of Review Antiphospholipid syndrome (APS) is a clinical disorder
characterised by thrombosis and/or pregnancy morbidity in the persistence of …